Overexpression of the Wiskott-Aldrich syndrome protein N-terminal domain in transgenic mice inhibits T cell proliferative responses via TCR signaling without affecting cytoskeletal rearrangements.
Wiskott-Aldrich syndrome (WAS) is an X-linked recessive disorder characterized by thrombocytopenia with small platelets, severe eczema, and recurrent infections due to defects in the immune system. The disease arises from mutations in the gene encoding the WAS protein (WASP), which plays a role as an adaptor molecule in signal transduction accompanied by cytoskeletal rearrangement in T cells. To investigate the functional domain of WASP, we developed transgenic mice overexpressing the WASP N-terminal region (exon 1-5) including the Ena/VASP homology 1 (pleckstrin homology/WASP homology 1) domain, in which the majority of mutations in WAS patients have been observed. WASP transgenic mice develop and grow normally under the specific pathogen-free environment, and showed normal lymphocyte development. However, proliferative responses and cytokine production induced by TCR stimulation were strongly inhibited in transgenic mice, whereas Ag receptor capping and actin polymerization were normal. These findings suggest that overexpressed Ena/VASP homology 1 (pleckstrin homology/WASP homology 1) domain of WASP inhibits the signaling from TCR without coupling of cytoskeletal rearrangement. WASP transgenic mice shown here could be valuable tools for further understanding the WASP-mediated processes.
Sato
M
M
Department of Molecular Biology and Immunology, National Institute of Agrobiological Sciences, GlaxoWellcome, Ibaraki, Japan.
Tsuji
N M
NM
Gotoh
H
H
Yamashita
K
K
Hashimoto
K
K
Tadotsu
N
N
Yamanaka
H
H
Sekikawa
K
K
Hashimoto
Y
Y
D000199:Actins / Q000378:metabolism; D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D018389:Codon, Nonsense; D016207:Cytokines / Q000378:metabolism; D003599:Cytoskeleton / Q000648:ultrastructure*; D007166:Immunosuppressive Agents / Q000378:metabolism*; D008213:Lymphocyte Activation; D051379:Mice; D008822:Mice, Transgenic; D020125:Mutation, Missense; D010047:Ovalbumin / Q000276:immunology; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology; D010976:Platelet Count; D017434:Protein Structure, Tertiary; D011506:Proteins / Q000235:genetics / Q000378:metabolism*; D011940:Receptor Aggregation; D011948:Receptors, Antigen, T-Cell / Q000378:metabolism*; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D014611:Vaccination; D014923:Wiskott-Aldrich Syndrome; D051316:Wiskott-Aldrich Syndrome Protein
D000199:Actins; D018389:Codon, Nonsense; D016207:Cytokines; D007166:Immunosuppressive Agents; D010446:Peptide Fragments; D011506:Proteins; D011948:Receptors, Antigen, T-Cell; C495768:Was protein, mouse; D051316:Wiskott-Aldrich Syndrome Protein; D010047:Ovalbumin